Form 4: Amylyx Pharmaceuticals Executive Sells Shares
Insider Transaction (Form 4)
Gina Mazzariello, Chief Legal Officer of Amylyx Pharmaceuticals, Inc., sold 9,536 shares of common stock on September 10, 2026.
Summary
- Open-market sale: disposed of 9,525 Common Stock at $32.46 ($309,140) on September 10, 2026; holds 190,849 after (Direct).
- Open-market sale: disposed of 11 Common Stock at $33.34 ($367) on September 10, 2026; holds 190,838 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $309,506 of stock on the open market.
Insider Transactions
Gina Mazzariello — Officer (Chief Legal Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-10 | Open-market sale | Common Stock | 9,525 | $32 | $309.1K | 190,849 |
| 2026-09-10 | Open-market sale | Common Stock | 11 | $33 | $367 | 190,838 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-10 | Open-market sale (9,525 shares) |
| 2026-09-10 | Open-market sale (11 shares) |
Keywords
insider transaction, Form 4, AMLX, Amylyx Pharmaceuticals, Inc., bearish, Gina Mazzariello
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.